According to AtriCure's latest financial reports the company's total debt is NZ$0.12 Billion. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | NZ$0.13 B | 15.2% |
2023-12-31 | NZ$0.11 B | 0.32% |
2022-12-31 | NZ$0.11 B | 8.54% |
2021-12-31 | NZ$0.10 B | 5.48% |
2020-12-31 | NZ$0.10 B | -9.62% |
2019-12-31 | NZ$0.11 B | 45.09% |
2018-12-31 | NZ$78.2 M | 48.43% |
2017-12-31 | NZ$52.69 M | -6.15% |
2016-12-31 | NZ$56.14 M | 171.39% |
2015-12-31 | NZ$20.68 M | 299.76% |
2014-12-31 | NZ$5.17 M | -34.06% |
2013-12-31 | NZ$7.84 M | -23.46% |
2012-12-31 | NZ$10.25 M | 23.72% |
2011-12-31 | NZ$8.28 M | 123.98% |
2010-12-31 | NZ$3.7 M | -45.11% |
2009-12-31 | NZ$6.74 M | -35.55% |
2008-12-31 | NZ$10.46 M | 623.44% |
2007-12-31 | NZ$1.44 M | -6.02% |
2006-12-31 | NZ$1.53 M | -27.66% |
2005-12-31 | NZ$2.12 M |
Company | Total debt/th> | differencediff. | Country |
---|---|---|---|
![]() Teleflex TFX | NZ$3.30 B | 2,489.98% | ๐บ๐ธ USA |
![]() Cooper Companies COO | NZ$4.26 B | 3,239.75% | ๐บ๐ธ USA |
![]() Boston Scientific BSX | NZ$19.30 B | 15,024.07% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | NZ$1.15 B | 803.47% | ๐บ๐ธ USA |
![]() Abiomed ABMD | N/A | N/A | ๐บ๐ธ USA |
![]() Johnson & Johnson JNJ | NZ$86.14 B | 67,397.71% | ๐บ๐ธ USA |
![]() Medtronic MDT | NZ$43.86 B | 34,270.20% | ๐ฎ๐ช Ireland |